This is really important. Stuff getting publicized *without a paper* and without sufficient time for many scientists to look at, digest, comment and contextualize can lead to terrible outcomes—needlessly scaring people. We saw that happen with widely misreported studies before.https://twitter.com/EricTopol/status/1364769339434409984 …
-
Show this thread
-
It’s not about formal peer review per se. It’s just that many eyes are always better than a few, even if those few are excellent because they’re still a few, and a bit of time is better than rushing unless there’s something truly urgent that can’t wait another day or two.
3 replies 8 retweets 119 likesShow this thread -
zeynep tufekci Retweeted Nathan Grubaugh
What’s the hurry? I am constantly fielding inquiries from people who are losing hope—I mean this, losing hope and suffering greatly—after reading such stories. Is it justified? Who knows without a paper? Just put the draft paper somewhere and let a couple of days pass.https://twitter.com/NathanGrubaugh/status/1364782285954899968 …
zeynep tufekci added,
Nathan Grubaugh @NathanGrubaughThis wasn't even a "pre-print" - I was asked to provide comment on someone's draft manuscript that still had tracked changes and didn't include the figures. Based on this, the NYT wrote a story. This is an absolute mess. https://twitter.com/EricTopol/status/1364769339434409984 …Show this thread7 replies 13 retweets 119 likesShow this thread -
Replying to @zeynep
I see you bring this up often lately but isn't this the 'second order impact' analysis that you often dislike? Doesn't make sense to not talk about variants cause someone might get overly worried.
1 reply 0 retweets 0 likes -
Replying to @firasd
We can talk about them the next day, after the scientific community had a chance to see the paper and digest and respond to the news. I'm not saying ignore it at all. Give it a day! The online scientific community response is really, really fast these days.
1 reply 0 retweets 0 likes -
Replying to @zeynep
Sure I agree in this case (I didn't post the story about the 'CA variant' to my
@covidpath aggregator cause it seemed ambiguous). But I've also seen you take objection to commentary on studies about comparative efficacy etc. I do agree we are in the endgame so nobody should panic1 reply 0 retweets 0 likes
Those—comparing efficacy—are largely being misreported, though, that's the problem. Different issue. Otherwise, of course, fine to inform people. I'm going to write longer on why and how on that one soon.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.